1996 Fiscal Year Final Research Report Summary
S19 RIBOSOMAL PROTEIN DIMER AS MONOCYTE CHEMOTACTIC FACTOR IN CHRONIC INFLAMMATION.
| Project/Area Number |
08457072
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Experimental pathology
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
YAMAMOTO Tetsuro KUMAMOTO UNIVERSITY SCHOOL OF MEDICINE,PROFESSOR, 医学部, 教授 (60112405)
|
|---|
| Project Period (FY) |
1996
|
| Keywords | S19 ribosomal protein / transglutaminases / chemical mediators / monocytes / macrophages / chemotactic factor / recombinant protein / rheumatoid arthritis |
|---|
| Research Abstract |
The extracts of rheumatoid arthritis-synovial lesions from seven patients possessed a strong chemotactic activity for monocytes and a negligible one for polymorphonuclear leukocytes. These results are consistent with a prominent histological feature of the synovial lesion, the mononuclear cell predominant infiltration. The major monocyte chemotactic factor in the synovial tissue extracts was purified to a single protein peak in reverse phase HPLC with a C4 column. NH_2-terminal amino acid analysis of the initial twenty residues yielded a single sequence. Surprisingly, this sequence was completely identical to that of S19 ribosomal protein. The purified sample demonstrated two protein bands in SDS-PAGE with apparent molecular masses of 34 k and 68 k. These sizes were two and four times that of S19 ribosomal protein suggesting that the chemotactic factor would be a dimer or tetramer of S19 ribosomal protein cross-linked by factor XIIIa. A recombinant human S19 ribosomal protein was prepared as a fusion protein with a maltose binding protein in E.coli. After treatment with factor XIIIa, cross-linked recombinant S19 ribosomal protein exhibited the monocyte chemotactic activity although the untreated recombinant protein did not.
|
